Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03620071
What this trial is testing

GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity

Who this might be right for
Childhood CancerCerebral PalsyChronic Lung Disease+3 more
Stanford University 67
Testing effectiveness (Phase 2)Looking for participantsNCT06810544
What this trial is testing

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Who this might be right for
Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more
Tango Therapeutics, Inc. 191
Testing effectiveness (Phase 2)Looking for participantsNCT07208773
What this trial is testing

YL201 and Ivonescimab (AK112) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon Small Cell Lung CancerSmall Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. 260
Testing effectiveness (Phase 2)Ended earlyNCT02403895
What this trial is testing

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
AstraZeneca 11
Large-scale testing (Phase 3)Study completedNCT04768075
What this trial is testing

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Guangdong Association of Clinical Trials 60
Not applicableEnded earlyNCT01363557
What this trial is testing

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

Who this might be right for
EGFR-mutated Lung AdenocarcinomaBrain Metastasis
Assistance Publique - Hôpitaux de Paris 1
Not applicableWithdrawnNCT02877966
What this trial is testing

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Who this might be right for
Cancer Patients With Cachexia
Helsinn Healthcare SA
Testing effectiveness (Phase 2)Looking for participantsNCT06106802
What this trial is testing

Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Sehhoon Park 47
Testing effectiveness (Phase 2)Study completedNCT00606502
What this trial is testing

Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

Who this might be right for
Non-small Cell Lung Cancer
Spectrum Pharmaceuticals, Inc 201
Not applicableStudy completedNCT04314284
What this trial is testing

Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

Who this might be right for
Gynecologic CancerColorectal CancerLung Cancer
Washington University School of Medicine 150
Testing effectiveness (Phase 2)Study completedNCT01174563
What this trial is testing

A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07627321
What this trial is testing

Becotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for Driver-Gene-Negative, EGFR-Expression-Positive Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Anhui Provincial Cancer Hospital 39
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)UnknownNCT02284490
What this trial is testing

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Who this might be right for
Brain Metastases
Rongjie Tao 25
Testing effectiveness (Phase 2)UnknownNCT05435274
What this trial is testing

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small-Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 380
Testing effectiveness (Phase 2)Looking for participantsNCT06738160
What this trial is testing

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCStereotactic Body Radiation Therapy (SBRT)Immunotherapy
Fudan University 27
Testing effectiveness (Phase 2)Looking for participantsNCT06243003
What this trial is testing

WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases

Who this might be right for
SCLC,Extensive StageBrain Metastases
Fudan University 56
Early research (Phase 1)Study completedNCT03216343
What this trial is testing

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Chipscreen Biosciences, Ltd. 48
Large-scale testing (Phase 3)Looking for participantsNCT07668752
What this trial is testing

Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationNSCLC (Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc. 300
Testing effectiveness (Phase 2)Looking for participantsNCT05419076
What this trial is testing

Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Metastases+3 more
Memorial Sloan Kettering Cancer Center 62
Next Page